BioCentury
ARTICLE | Distillery Therapeutics

Cancer

September 20, 2017 6:57 PM UTC

Patient sample, cell culture and mouse studies suggest inhibiting ZNF395 could help treat clear cell renal cell carcinoma (ccRCC). In patients, levels of ZNF395 were higher in tumors than in normal re...

BCIQ Company Profiles

Duke-NUS Medical School